Showing 6931-6940 of 8649 results for "".
- Ophthalmic Investment Funds Led by Retinal Gene Therapy Developershttps://modernod.com/news/ophthalmic-investment-funds-led-by-retinal-gene-therapy-developers/2476147/Ophthalmology remains one of the most active areas of medical technology investment, attracting monies from venture capitalists, public markets, large ophthalmic companies, and private equity. Market Scope just published its 2017/2018 Ophthalmic Deals Book, analyzing recent ophthalmic fund
- Eyenovia Publishes PG21 Phase 2 Trial Results Examining IOP Lowering Effect and Patient Usabilityhttps://modernod.com/news/eyenovia-publishes-pg21-phase-2-trial-results-examining-iop-lowering-effect-and-patient-usability/2479637/Eyenovia announced that the full results of its phase 2 PG21 study have been published in the article “Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose” in the November issue of the peer-
- Opternative Secures $9M in Most Recent Round of Fundinghttps://modernod.com/news/opternative-secures-9m-in-most-recent-round-of-funding/2479683/Opternative announced it has secured $9 million in its latest round of funding. The round of financing was led by Trust Ventures and Pritzker Group Venture Capital, with an additional investment from existing investor Jump Capital. Opternative will use the fun
- Millennial Demographics Drive Refractive Surgery Opportunity in UShttps://modernod.com/news/millennial-demographics-drive-refractive-surgery-opportunity-in-us/2479686/Wealth, health, and education are key factors in determining the opportunity for laser vision correction (LVC) procedures in the US, according to new Market Scope data. Refractive procedures are strongly driven by the country’s millennial population, and the high opportunity population is
- Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis Systemhttps://modernod.com/news/second-sight-announces-final-2019-medicare-hospital-outpatient-payment-rate-for-the-argus-ii-retinal-prosthesis-system/2479688/Second Sight Medical Products
- Webinar Today: Create a Winning Search Strategy for LASIK Practiceshttps://modernod.com/news/webinar-today-create-a-winning-search-strategy-for-lasik-practices/2479691/Workshop Digital, a digital marketing company in Virginia, and Google have partnered to host a live webinar at 4
- Clerio Vision: First Noninvasive Laser Vision Correction Procedures Performedhttps://modernod.com/news/clerio-vision-first-noninvasive-laser-vision-correction-procedures-performed/2479743/Leveraging technology developed at the University of Rochester that was recently recognized with a Nobel Prize, Clerio Vision is commercializing LIRIC—a novel, noninvasive method to correct human vision. The core technology has been in development for more than 15 year
- Oculus Announces New Joystick for the Keratograph 5M With Release Functionhttps://modernod.com/news/oculus-announces-new-joystick-for-the-keratograph-5m-with-release-function/2479779/As of September 2018, the Oculus Keratograph 5M comes equipped with a new joystick including a release function. This enables the user to capture images and video sequences with the simple push of a button on the devi
- Falls in Elders May Be Driving Up Secondary Diagnoses of Eye Traumahttps://modernod.com/news/falls-in-elders-may-be-driving-up-secondary-diagnoses-of-eye-trauma/2479788/Hospital admissions due to eye trauma have declined since 2001, but more and more patients are being admitted with a secondary diagnosis of eye trauma, largely due to an increase in falls among older people, new findings suggest, according to a Reuters
- Novartis to File for New Lucentis (Ranibizumab) Indication in Retinopathy of Prematurity (ROP)https://modernod.com/news/novartis-to-file-for-new-lucentis-ranibizumab-indication-in-retinopathy-of-prematurity-rop/2479845/Novartis announced results from a phase 3 study of Lucentis (ranibizumab) versus laser surgery (the current standard of care) in premature infants with retinopathy of prematurity (ROP). Unlike laser surgery, which damages eye tissue and can be associated with significant complications such as hig